Motif ID: Meis1
Z-value: 0.862
Transcription factors associated with Meis1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Meis1 | ENSMUSG00000020160.12 | Meis1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Meis1 | mm10_v2_chr11_-_19018956_19018973 | 0.31 | 1.7e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.5 | 12.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 1.1 | 3.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 1.0 | 5.1 | GO:0015867 | ATP transport(GO:0015867) |
| 1.0 | 5.8 | GO:0003383 | apical constriction(GO:0003383) |
| 0.9 | 3.5 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.7 | 2.8 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.7 | 2.0 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.6 | 1.9 | GO:0007521 | muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 0.6 | 1.9 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.6 | 3.6 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.6 | 2.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.5 | 2.7 | GO:0015705 | iodide transport(GO:0015705) |
| 0.5 | 2.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.5 | 9.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.5 | 1.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
| 0.4 | 1.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.4 | 1.3 | GO:0046878 | operant conditioning(GO:0035106) sperm ejaculation(GO:0042713) positive regulation of saliva secretion(GO:0046878) |
| 0.4 | 1.7 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.4 | 2.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.4 | 1.1 | GO:0010986 | complement receptor mediated signaling pathway(GO:0002430) GPI anchor release(GO:0006507) positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.4 | 1.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 | 1.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.4 | 1.8 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.4 | 1.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) negative regulation of t-circle formation(GO:1904430) |
| 0.3 | 1.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 0.3 | 1.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 1.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.3 | 1.7 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.3 | 0.8 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.3 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.3 | 2.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.3 | 1.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.3 | 1.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.3 | 0.8 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.2 | 0.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 0.2 | 1.7 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.2 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 | 5.9 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.2 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 | 1.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 | 0.6 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 | 0.9 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 | 0.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.2 | 0.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.2 | 2.8 | GO:0060065 | uterus development(GO:0060065) |
| 0.2 | 2.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.2 | 1.4 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.2 | 3.9 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.2 | 1.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.2 | 1.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 1.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.1 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.1 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 | 2.3 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 | 0.3 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
| 0.1 | 0.7 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 | 0.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 1.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 3.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 1.3 | GO:0010388 | cullin deneddylation(GO:0010388) |
| 0.1 | 1.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.1 | 0.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 | 5.7 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 | 0.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.1 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 0.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 2.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 0.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.1 | 0.5 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.1 | 0.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 3.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 | 3.9 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.0 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.0 | 3.6 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.0 | 1.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 1.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 | 1.6 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.0 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.0 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 1.4 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 3.6 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.0 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 1.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 3.4 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 0.0 | 0.5 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.0 | 2.8 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.0 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
| 0.0 | 1.0 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 | 1.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 | 3.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
| 0.0 | 1.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 1.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
| 0.0 | 2.3 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.0 | 0.3 | GO:0007099 | centriole replication(GO:0007099) |
| 0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 0.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.0 | 1.5 | GO:0000910 | cytokinesis(GO:0000910) |
| 0.0 | 1.7 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.5 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.0 | 0.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.0 | 1.4 | GO:0008033 | tRNA processing(GO:0008033) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.2 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 1.0 | 3.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.9 | 3.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.7 | 5.8 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.4 | 1.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.3 | 2.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 3.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 1.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.2 | 1.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.2 | 0.9 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.2 | 1.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 2.3 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 0.5 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.1 | 1.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.8 | GO:0001740 | Barr body(GO:0001740) |
| 0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.1 | 0.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 1.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.1 | 3.4 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.1 | 10.7 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.1 | 1.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 1.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.9 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.0 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 19.8 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 3.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 2.7 | GO:0016234 | inclusion body(GO:0016234) |
| 0.0 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 2.0 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 2.7 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 0.7 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.0 | 1.2 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 1.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 2.5 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.9 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.0 | 0.7 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.0 | 2.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 1.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 1.5 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 2.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 1.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 2.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 2.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 0.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 1.3 | 5.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
| 0.8 | 7.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.7 | 2.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.6 | 4.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.5 | 2.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.5 | 3.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.5 | 3.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 3.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.4 | 3.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.4 | 2.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.4 | 1.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.3 | 2.1 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.3 | 1.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.3 | 3.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.3 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.3 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.3 | 1.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.2 | 3.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 1.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.2 | 0.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.2 | 0.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.2 | 3.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.2 | 1.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 2.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.2 | 0.7 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
| 0.2 | 0.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.1 | 1.0 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.1 | 0.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 0.8 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 5.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.1 | 3.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 1.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 2.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 1.4 | GO:0005536 | glucose binding(GO:0005536) |
| 0.1 | 2.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.1 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.3 | GO:0032138 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
| 0.1 | 1.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.1 | 1.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.1 | 2.6 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 1.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 1.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.2 | GO:0015173 | hydrogen:amino acid symporter activity(GO:0005280) aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 1.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.0 | 3.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 2.7 | GO:0020037 | heme binding(GO:0020037) |
| 0.0 | 0.9 | GO:0008187 | poly(A) binding(GO:0008143) poly-pyrimidine tract binding(GO:0008187) poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.0 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.0 | 0.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.0 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 0.4 | GO:0034943 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
| 0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.0 | 1.7 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
| 0.0 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.0 | 37.4 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
| 0.0 | 1.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.0 | 1.8 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 1.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 5.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.0 | 0.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.2 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
| 0.0 | 1.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 1.0 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.0 | 3.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 1.0 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 0.3 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
| 0.0 | 0.9 | GO:0008565 | protein transporter activity(GO:0008565) |
